Sponsored by: Dell EMC
In January 2015, President Obama announced the Precision Medicine Initiative; a bold new research effort to revolutionize how we improve health and treat disease in the United States. Its goal is to bring precision medicine, an approach to disease management that considers individual variability in genes, environment, and lifestyle, into the field of cancer and then ultimately into all areas of health and health care; thus moving away from the “one size fits all” approach for treatments.
Advances in Precision Medicine have already led to powerful new discoveries and new treatments that are tailored to an individual’s specific genetic makeup or genetic profile. This is one step in transforming the way we can treat disease.
As consumers show more and more interest in their individual genetic information, the pressure for healthcare delivery organizations to personalize diagnosis and treatment plans will intensify. Those who are slow to adopt will likely lose customers in this new era of data driven healthcare.
In this session, we will explore:
- The market and technology trends that are accelerating the healthcare sector’s adoption of Precision Medicine
- The practice areas that are getting the most traction with early adopters that offer the greatest promise
- The opportunities for the health IT industry to bring innovative solutions that address current technology challenges
- The expectations we should have on providers, payers, pharma, policy and patients to accelerate precision medicine
Please enter your email address to access this resource